PD-1/PD-L1 inhibitors have shown very good results in treating patients with some solid tumors, including melanoma, lung cancer, kidney cancer, and head and neck cancer, where prolonged OS was seen in patients 32. The gene discussed is CD274; the disease is melanoma.